CavalierChem acquired an unprofitable surfactants manufacturing facility and needs guidance on what to do with it. Analysis reveals that while CavalierChem and its competitor have identical costs (5.5 cents/lb total), the competitor generates 4x higher profit margins through superior pricing (7.67 vs 5.67 cents/lb on contracts). The case explores three options: renegotiating contracts (+$210M over 5 years), repurposing the facility for other products (+$175M), or divesting (+$200M).
Key Insights:
- Profitability problems stem from pricing strategy, not operational inefficiency—the candidate must recognize identical costs but vastly different profits indicate a pricing issue
- The framework emphasizes considering multiple strategic alternatives (increase profitability, repurpose, divest) rather than fixating on a single solution
- Acquisition price is a sunk cost and should not influence forward-looking decisions about the facility’s future
- Total cash flow over the 5-year horizon is the key metric for comparing options, requiring the candidate to calculate incremental profits and capital expenditures